國立高雄大學圖資館 |

Language: English

Back

Pharmacology of the WNT signaling system

Kozielewicz, Pawel.

Pharmacology of the WNT signaling system

Record Type:	Electronic resources : Monograph/item
Title/Author:	Pharmacology of the WNT signaling systemedited by Gunnar Schulte, Pawel Kozielewicz.
other author:	Schulte, Gunnar.
Published:	Cham :Springer International Publishing :2021.
Description:	viii, 422 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Wnt pathway.
Online resource:	https://doi.org/10.1007/978-3-030-85499-7
ISBN:	9783030854997$q(electronic bk.)

Pharmacology of the WNT signaling system
Pharmacology of the WNT signaling system[electronic resource] /edited by Gunnar Schulte, Pawel Kozielewicz. - Cham :Springer International Publishing :2021. - viii, 422 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v. 2691865-0325 ;. - Handbook of experimental pharmacology ;208..

Pharmacological thinking in WNT signaling -- Controlling WNT Signaling Specificity and implications for targeting WNTs pharmacologically -- WNTs on exosomes -- Strategies to target LRPs in WNT signaling -- Targeting the receptor tyrosine kinase ROR1 by small molecules -- Assessing WNT binding and Frizzled activation employing genetically encoded, biophysical sensors -- Disheveled proteins as crucial mediators of WNT signaling -- Destruction complex and regulation of CTNNB1 -- Strategies to therapeutically target WNT/PCP like signaling in disease -- Mining natural compounds to target WNT signaling - from mushrooms to corals -- FZD7 as a therapeutic target in intestinal cancer -- Targeting oncogenic WNT signaling with WNT derived peptides -- Targeting WNT signaling in lung pathology -- The role of WNT signaling in osteoarthritis and the therapeutic potential of its pharmacological targeting -- WNT signaling in Alzheimers disease and other neurodegenerative disorders - opportunities for therapy? -- Targeting WNT signaling as a risk.

This book reflects the state of the art of our understanding of the WNT signaling system, which comprises a network of signaling pathways initiated by the secreted WNT lipoglycoproteins, which are crucial for embryonal development, stem cell regulation, tissue homeostasis and repair. Dysfunction of this evolutionarily conserved signaling system leads to many diseases including developmental disorders, diverse forms of cancer, fibrosis, neurodegenerative disease and many more. The WNT signaling system is built upon 19 mammalian, secreted WNT lipoglycoproteins that interact with a plethora of distinct receptors, such as the G protein-coupled receptors called Frizzleds (FZD1-10), LDL receptor-like proteins (LRP5/6), receptor tyrosine kinases (ROR1, 2, RYK and PTK7) In addition, WNT pathways are tightly regulated by many secreted and cell-intrinsic negative regulators, such as soluble FZD-related proteins (SFRPs), Dickkopfs (DKKs), WNT-inhibitory proteins, TIKI, RNF43 and more. Understanding the basic mechanism in terms of receptor-ligand interaction, receptor selectivity, signal initiation and desensitization remain poorly understood, even though substantial advances have been made the recent years. Due to the involvement of the WNT signaling system in human disease, it appears obvious to target diverse branches pharmacologically and therapeutically. However, given the complexity of the system and its importance for stem cell regulation and tissue maintenance, therapy comes with obvious risks for severe side effects. The field is addressing the challenge to identify suitable targets and selective compounds for therapy allowing disease-selective therapeutic effects and balancing unwanted side effects. This book summarizes the current understanding of the basic and applied pharmacology in the WNT signaling system and bridges disciplines such as pharmacology, physiology, neurosciences, oncology and drug development.

ISBN: 9783030854997$q(electronic bk.)

Standard No.: 10.1007/978-3-030-85499-7doiSubjects--Topical Terms:

908410
Wnt pathway.

LC Class. No.: QP517.C45 / P53 2021

Dewey Class. No.: 572.64

Pharmacology of the WNT signaling system
LDR:04064nmm a2200337 a 4500 001 610365
003 DE-He213
005 20211029173813.0
006 m d
007 cr nn 008maaau
008 220330s2021 sz s 0 eng d
020 $a 9783030854997$q(electronic bk.)
020 $a 9783030854980$q(paper)
024 7 $a 10.1007/978-3-030-85499-7 $2 doi
035 $a 978-3-030-85499-7
040 $a GP $c GP
041 0 $a eng
050 4 $a QP517.C45 $b P53 2021
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 572.64 $2 23
090 $a QP517.C45 $b P536 2021
245 0 0 $a Pharmacology of the WNT signaling system $h [electronic resource] / $c edited by Gunnar Schulte, Pawel Kozielewicz.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a viii, 422 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 1865-0325 ; $v v. 269
505 0 $a Pharmacological thinking in WNT signaling -- Controlling WNT Signaling Specificity and implications for targeting WNTs pharmacologically -- WNTs on exosomes -- Strategies to target LRPs in WNT signaling -- Targeting the receptor tyrosine kinase ROR1 by small molecules -- Assessing WNT binding and Frizzled activation employing genetically encoded, biophysical sensors -- Disheveled proteins as crucial mediators of WNT signaling -- Destruction complex and regulation of CTNNB1 -- Strategies to therapeutically target WNT/PCP like signaling in disease -- Mining natural compounds to target WNT signaling - from mushrooms to corals -- FZD7 as a therapeutic target in intestinal cancer -- Targeting oncogenic WNT signaling with WNT derived peptides -- Targeting WNT signaling in lung pathology -- The role of WNT signaling in osteoarthritis and the therapeutic potential of its pharmacological targeting -- WNT signaling in Alzheimers disease and other neurodegenerative disorders - opportunities for therapy? -- Targeting WNT signaling as a risk.
520 $a This book reflects the state of the art of our understanding of the WNT signaling system, which comprises a network of signaling pathways initiated by the secreted WNT lipoglycoproteins, which are crucial for embryonal development, stem cell regulation, tissue homeostasis and repair. Dysfunction of this evolutionarily conserved signaling system leads to many diseases including developmental disorders, diverse forms of cancer, fibrosis, neurodegenerative disease and many more. The WNT signaling system is built upon 19 mammalian, secreted WNT lipoglycoproteins that interact with a plethora of distinct receptors, such as the G protein-coupled receptors called Frizzleds (FZD1-10), LDL receptor-like proteins (LRP5/6), receptor tyrosine kinases (ROR1, 2, RYK and PTK7) In addition, WNT pathways are tightly regulated by many secreted and cell-intrinsic negative regulators, such as soluble FZD-related proteins (SFRPs), Dickkopfs (DKKs), WNT-inhibitory proteins, TIKI, RNF43 and more. Understanding the basic mechanism in terms of receptor-ligand interaction, receptor selectivity, signal initiation and desensitization remain poorly understood, even though substantial advances have been made the recent years. Due to the involvement of the WNT signaling system in human disease, it appears obvious to target diverse branches pharmacologically and therapeutically. However, given the complexity of the system and its importance for stem cell regulation and tissue maintenance, therapy comes with obvious risks for severe side effects. The field is addressing the challenge to identify suitable targets and selective compounds for therapy allowing disease-selective therapeutic effects and balancing unwanted side effects. This book summarizes the current understanding of the basic and applied pharmacology in the WNT signaling system and bridges disciplines such as pharmacology, physiology, neurosciences, oncology and drug development.
650 0 $a Wnt pathway. $3 908410
650 0 $a Wnt proteins. $3 229406
650 0 $a Neuropharmacology. $3 275141
650 1 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Physiology. $3 192980
650 2 4 $a Oncology. $3 195181
650 2 4 $a Neurosciences. $3 211508
650 2 4 $a Developmental Biology. $3 275108
700 1 $a Schulte, Gunnar. $3 908408
700 1 $a Kozielewicz, Pawel. $3 908409
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 559421
856 4 0 $u https://doi.org/10.1007/978-3-030-85499-7
950 $a Biomedical and Life Sciences (SpringerNature-11642)